New study tracks nerve damage marker in rare genetic disease
NCT ID NCT06360289
First seen Nov 17, 2025 · Last updated May 08, 2026 · Updated 19 times
Summary
This study looks at a protein called NfL in the blood of people who carry a TTR gene variant, both those without symptoms and those with hATTR amyloidosis affecting nerves. The goal is to see if NfL levels can help detect when the disease starts, how it progresses, and how well treatments work. About 500 participants will be followed over time at a single center.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire (CHU) Le Kremlin-Bicêtre Assistance Publique-Hôpitaux de Paris (APHP)
RECRUITINGParis, Île-de-France Region, 94270, France
Conditions
Explore the condition pages connected to this study.